San Francisco Street Medicine low-barrier buprenorphine pilot (2016-2017)
The San Francisco Street Medicine Team began prescribing buprenorphine to homeless people who injected heroin without requiring abstinence. The program enrolled 95 people; 63% stayed in care at one month and 37% were still on buprenorphine.
The study found intermittent treatment was common, with 18% still on buprenorphine at 12 months.
It showed low-barrier prescribing could engage people who were otherwise out of care, but retention remained the central challenge.
The new SoMa pilot uses a similar low-barrier approach, and the old numbers set the benchmark for judging whether it works.
